The novel approach of the medication represents a major advance in the handling of type 2 diabetes. Different to existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide242528.thechapblog.com/40801480/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment